Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: The effect of bisphosphonate therapy on bone scintigraphy results

By Roudier M.P.   Vesselle H.   True L.D.   Higano C.S.   Ott S.M.   King S.H.   Vessella R.L.  

Clinical and Experimental Metastasis, Vol. 20, Iss. 2, 2003-03 ,pp. : 171-180

Springer Publishing Company

Access to resources Recommend Favorite

Imaging in prostate cancer

By Abdellaoui Adel   Iyengar Srikanth   Freeman Simon  

Future Oncology, Vol. 7, Iss. 5, 2011-05 ,pp. : 679-691

Future Medicine

Access to resources Recommend Favorite

Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy

By Cheung R.   Tucker S.L.   Dong L.   Kuban D.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 56, Iss. 5, 2003-08 ,pp. : 1234-1240

Elsevier

Access to resources Recommend Favorite

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

By Zelefsky M.J.   Fuks Z.   Hunt M.   Yamada Y.   Marion C.   Ling C.C.   Amols H.   Venkatraman E.S.   Leibel S.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 306-307

Elsevier

Access to resources Recommend Favorite

Reducing biochemical recurrence rates in EBRT-treated prostate cancer patients: the influence of dose and dose per fraction

By Lee W Robert  

Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. : 649-654

Future Medicine

Access to resources Recommend Favorite